Takasago achieves record FY2024 sales, forecasts slight revenue growth for FY2025

Takasago International Corporation (TSE: 4914) announced record financial results for the fiscal year ended March 2025, driven by robust performance in flavors, fragrances, and fine chemicals, particularly due to an increase in export of pharmaceutical intermediates, through optimization of product mix and sales increased . Net sales surged 17% year-over-year to JPY229.2 billion. Operating profit also reached a record high of JPY15.3 billion, reflecting improved gross profit margins due to optimized product mix and lower raw material prices. ROE exceeded the company's target at 9.8%.